학술논문
New-onset cardiac amyloidosis while in remission from systemic AL amyloidosis
Document Type
article
Source
European Journal of Case Reports in Internal Medicine (2023)
Subject
Language
English
ISSN
2284-2594
Abstract
In light chain amyloidosis, a reduction in dFLC to below 40 mg/l is a prerequisite for organ recovery as nearly half of the patients who achieve very good partial haematological responses have improvement in the function of the involved organ. We describe a patient who developed new-onset cardiac amyloidosis despite a post-treatment reduction in dFLC to